Pain Clinical Trial
Official title:
A Randomized, Controlled Trial Comparing Air Insufflation, Water Immersion and Water Exchange for Adenoma Detection Rate in Screening Colonoscopy
Verified date | March 2016 |
Source | Presidio Ospedaliero Santa Barbara |
Contact | n/a |
Is FDA regulated | No |
Health authority | Italy: Ethics Committee |
Study type | Interventional |
The degree of protection afforded by colonoscopy against proximal colorectal cancer (CRC)
appears to be related to the quality of the procedure, and the incomplete removal of lesions
has been shown to increase the subsequent risk of developing a colon cancer.
Some studies suggest that small polyps with advanced histology are more common in the right
than in the left colon (right colon proximal to splenic flexure, left colon distal to the
splenic flexure). The average size of polyps in the right colon with advanced pathology or
containing adenocarcinoma was ≤9 mm, whereas in the left colon their average size was >9 mm,
P<0.001. Inadequate prevention of right-sided CRC incidence and mortality may be due to
right-sided polyps with advanced histology or that harbor malignancy. These presumptive
precursors of cancer are smaller and possibly more easily obscured by residual feces, and
more likely to be missed at colonoscopy.
Water-aided colonoscopy (WAC) can be subdivided broadly into two major categories: water
immersion (WI), characterized by suction removal of the infused water predominantly during
the withdrawal phase of colonoscopy, and water exchange (WE), characterized by suction
removal of infused water predominantly during the insertion phase of colonoscopy.
In some reports WE appeared to be superior to both WI and air insufflation colonoscopy (AI)
in terms of pain reduction and adenoma detection, particularly for <10 mm adenomas in the
proximal colon.
In this multicenter, double-blinded randomized controlled trial (RCT) we test the hypothesis
that that WE, compared to AI and WI, will enhance overall Adenoma Detection Rate (ADR) in
CRC screening patients. Confirmation of the primary hypothesis will provide evidence that WE
enhances the quality of screening colonoscopy.
We also hypothesize that WE may be more effective in detecting proximal colon adenomas than
WI and AI, particularly <10 mm adenomas, thus increasing proximal colon ADR and proximal
colon ADR <10 mm. Confirmation of secondary hypotheses will provide justification for
further testing that WE may provide a strategy to improve prevention of colorectal cancer by
increasing detection of adenomas in screening colonoscopy.
Unlike previous reports of single colonoscopist studies, the insertion and withdrawal phases
of colonoscopy will be done by different investigators. The second investigator will be
blinded to the method used to insert the instrument, thus eliminating possible bias about
procedure related issues.
Several secondary outcomes will also be analysed.
Status | Active, not recruiting |
Enrollment | 1224 |
Est. completion date | April 2016 |
Est. primary completion date | March 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 50 Years to 70 Years |
Eligibility |
Inclusion Criteria: - consecutive screening patients Exclusion Criteria: - previous colonoscopy within 5 years - surveillance colonoscopy - previous colorectal surgery - indication for a proctosigmoidoscopy or bidirectional endoscopy - history of inflammatory bowel disease - patient refusal or inability to provide informed consent - inadequate consumption of bowel preparation |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)
Country | Name | City | State |
---|---|---|---|
Czech Republic | Digestive Diseases Center, Vìtkovice Hospital | Ostrava | |
Italy | Division of Gastroenterology, Ospedale Valduce | Como | CO |
Italy | Digestive Endoscopy Unit, Ospedale S. Barbara | Iglesias | CI |
United States | Sepulveda Ambulatory Care Center, VA Greater Los Angeles Healthcare System | Los Angeles | California |
Lead Sponsor | Collaborator |
---|---|
Presidio Ospedaliero Santa Barbara |
United States, Czech Republic, Italy,
Cadoni S, Gallittu P, Sanna S, Fanari V, Porcedda ML, Erriu M, Leung FW. A two-center randomized controlled trial of water-aided colonoscopy versus air insufflation colonoscopy. Endoscopy. 2014 Mar;46(3):212-8. doi: 10.1055/s-0033-1353604. Epub 2013 Nov 11. — View Citation
Gupta S, Balasubramanian BA, Fu T, Genta RM, Rockey DC, Lash R. Polyps with advanced neoplasia are smaller in the right than in the left colon: implications for colorectal cancer screening. Clin Gastroenterol Hepatol. 2012 Dec;10(12):1395-1401.e2. doi: 10.1016/j.cgh.2012.07.004. Epub 2012 Jul 24. — View Citation
Leung FW, Amato A, Ell C, Friedland S, Harker JO, Hsieh YH, Leung JW, Mann SK, Paggi S, Pohl J, Radaelli F, Ramirez FC, Siao-Salera R, Terruzzi V. Water-aided colonoscopy: a systematic review. Gastrointest Endosc. 2012 Sep;76(3):657-66. doi: 10.1016/j.gie.2012.04.467. Review. — View Citation
Leung FW. Water-aided colonoscopy. Gastroenterol Clin North Am. 2013 Sep;42(3):507-19. doi: 10.1016/j.gtc.2013.05.006. Review. — View Citation
Rabenstein T, Radaelli F, Zolk O. Warm water infusion colonoscopy: a review and meta-analysis. Endoscopy. 2012 Oct;44(10):940-51. doi: 10.1055/s-0032-1310157. Epub 2012 Sep 17. Review. — View Citation
Radaelli F, Paggi S, Amato A, Terruzzi V. Warm water infusion versus air insufflation for unsedated colonoscopy: a randomized, controlled trial. Gastrointest Endosc. 2010 Oct;72(4):701-9. doi: 10.1016/j.gie.2010.06.025. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Loop reduction maneuvers. | Applied as needed if advancement of the colonoscope fails. | 1 hour. | No |
Other | Position changes. Position changes. Position changes. Position changes. Position changes. | Change in patient position as needed if advancement of the colonoscope fails. | 1 hour. | No |
Other | Abdominal compression. | Compression of abdomen if advancement of the colonoscope fails. | 1 hour. | No |
Other | Amount of water used during the procedure. | Amount of water infused and aspirated during insertion and withdrawal. | 1 hour. | No |
Other | Patients willingness to repeat the examination. | Patients willingness to repeat the examination based on overall satisfaction about procedure. Measured at discharge on a yes/no question. | 1 hour. | No |
Primary | Adenoma Detection Rate. | Proportion of subjects with at least one adenoma of any size. | 18 months. | No |
Secondary | Proximal colon Adenoma Detection Rate. | Proportion of subjects with at least one adenoma of any size in the proximal colon. | 18 months. | No |
Secondary | Proximal colon <10 mm Adenoma Detection Rate. | Proportion of subjects with at least one adenoma <10 mm in the proximal colon. | 18 months. | No |
Secondary | Mean adenomas resected per procedure. | Total number of adenomas resected per subject. | 18 months. | No |
Secondary | Cecal intubation rate. | Cecal intubation will be defined as passage of the tip of the colonoscope beyond the ileocecal valve so that the medial wall of the cecum proximal to the ileocecal valve will be observed. | 1 hour. | No |
Secondary | Cecal intubation time. | Cecal intubation time will be defined as the time for passage of the colonoscope from the rectum to the cecum. | 1 hour. | No |
Secondary | Total procedure time. | Total procedure time (including time required for polyp resection or biopsy). | 1 hour. | No |
Secondary | Maximum pain score recorded during insertion phase of colonoscopy. | Pain will be measured on a visual analogue scale (VAS) with a score 0=absence of pain, 1-2=simply "discomfort", 10=the worst possible pain. Before the procedure, an endoscopic nurse will explain the VAS scoring system to the patient. Patient will be informed that the request for pain information is not to remind that the examination should be uncomfortable, but to let the colonoscopist be alerted to the need to use maneuvers to minimize discomfort (e.g. loop reduction, removal of colonic content, abdominal compression and/or change in patient position). At regular intervals during colonoscopy (e.g. every 60 seconds) patients will be asked about discomfort or pain. The responses will be recorded, and the maximum pain score noted. | 1 hour. | No |
Secondary | Pain score at discharge. | After the procedure and at discharge from the Endoscopy Unit, an assistant nurse blinded to the procedure will ask patients about maximum pain during insertion phase of the procedure using the same VAS when neither the endoscopist nor the assistant nurse who performed the colonoscopy will be present. Patients will be asked to quantify the degree of pain experienced and to place a mark over the VAS accordingly. | 1 hour. | No |
Secondary | Need for sedation/analgesia and its dosage | All patients will be offered sedation for the procedure. Patients can accept or decline the medication. If they accept, the procedure will be started with the administration of 2 mg of Midazolam intravenously (minimal sedation). If the patient will choose on-demand sedation, minimal sedation will be offered when pain score reaches =2 on the VAS. Patients can accept or decline the offered medication. If they accept, minimal sedation will be administered as described above. To avoid bias by the colonoscopist, sedation medication will be administered based on the patients' confirmation that the pain is no longer tolerable, and not at the discretion of the colonoscopist. The colon segment in which patients requests sedation will be recorded. If additional medication will be required despite the abovementioned maneuvers and/or minimal sedation, it will be provided according to local standards and it will be recorded. | 1 hour. | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05559255 -
Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI
|
N/A | |
Terminated |
NCT04356352 -
Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain
|
Phase 2/Phase 3 | |
Completed |
NCT04748367 -
Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care
|
N/A | |
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04466111 -
Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
|
||
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05868122 -
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
|
Phase 3 | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Completed |
NCT03273114 -
Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain
|
N/A | |
Enrolling by invitation |
NCT06087432 -
Is PNF Application Effective on Temporomandibular Dysfunction
|
N/A | |
Completed |
NCT05508594 -
Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001
|
Phase 2/Phase 3 | |
Recruiting |
NCT03646955 -
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
|
N/A | |
Active, not recruiting |
NCT03472300 -
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
|
||
Completed |
NCT03678168 -
A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries
|
N/A | |
Completed |
NCT03931772 -
Online Automated Self-Hypnosis Program
|
N/A | |
Completed |
NCT03286543 -
Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System
|
N/A | |
Completed |
NCT02913027 -
Can We Improve the Comfort of Pelvic Exams?
|
N/A | |
Terminated |
NCT02181387 -
Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor?
|
Phase 4 | |
Recruiting |
NCT06032559 -
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
|
Phase 3 | |
Active, not recruiting |
NCT03613155 -
Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care
|